Axsome Therapeutics Inc (AXSM)
76.22
-1.12
(-1.45%)
USD |
NASDAQ |
May 15, 15:37
Axsome Therapeutics Total Return Level: 77.34 for May 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 14, 2024 | 77.34 |
May 13, 2024 | 75.64 |
May 10, 2024 | 72.50 |
May 09, 2024 | 73.68 |
May 08, 2024 | 75.68 |
May 07, 2024 | 76.94 |
May 06, 2024 | 75.94 |
May 03, 2024 | 74.80 |
May 02, 2024 | 74.19 |
May 01, 2024 | 74.89 |
April 30, 2024 | 73.76 |
April 29, 2024 | 73.69 |
April 26, 2024 | 71.71 |
April 25, 2024 | 71.52 |
April 24, 2024 | 71.17 |
April 23, 2024 | 73.08 |
April 22, 2024 | 71.10 |
April 19, 2024 | 67.90 |
April 18, 2024 | 65.72 |
April 17, 2024 | 69.71 |
April 16, 2024 | 68.81 |
April 15, 2024 | 68.21 |
April 12, 2024 | 69.15 |
April 11, 2024 | 71.73 |
April 10, 2024 | 70.97 |
Date | Value |
---|---|
April 09, 2024 | 72.64 |
April 08, 2024 | 72.11 |
April 05, 2024 | 72.25 |
April 04, 2024 | 72.17 |
April 03, 2024 | 73.50 |
April 02, 2024 | 74.56 |
April 01, 2024 | 76.99 |
March 28, 2024 | 79.80 |
March 27, 2024 | 79.17 |
March 26, 2024 | 76.72 |
March 25, 2024 | 77.35 |
March 22, 2024 | 80.66 |
March 21, 2024 | 80.86 |
March 20, 2024 | 78.85 |
March 19, 2024 | 76.87 |
March 18, 2024 | 72.54 |
March 15, 2024 | 75.54 |
March 14, 2024 | 69.74 |
March 13, 2024 | 69.90 |
March 12, 2024 | 69.39 |
March 11, 2024 | 70.93 |
March 08, 2024 | 73.92 |
March 07, 2024 | 72.04 |
March 06, 2024 | 72.15 |
March 05, 2024 | 76.62 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
16.71
Minimum
Oct 01 2019
106.24
Maximum
Dec 26 2019
58.33
Average
64.05
Median
Mar 10 2021
Total Return Level Benchmarks
Krystal Biotech Inc | 159.47 |
Catalyst Pharmaceuticals Inc | 16.49 |
Vertex Pharmaceuticals Inc | 428.59 |
Vistagen Therapeutics Inc | 4.52 |
ADMA Biologics Inc | 9.16 |